Vivek Subbiah

M D Anderson Cancer Center University of Texas - Houston / United States

Medical and Health Sciences / Medical Oncology

AD Scientific Index ID: 1406964

MD Anderson Cancer Center

Go Premium -
Unlock Full Profile Tools

Get Your Global Impact Certificate

M D Anderson Cancer Center University of Texas

Vivek Subbiah's MOST POPULAR ARTICLES

1-) Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations New England Journal of Medicine 373 (8), 726-736, 2015

2-) Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study The Lancet 395 (10241), 1907-1918, 2020

3-) Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer Journal of Clinical Oncology 36 (1), 7-13, 2018

4-) Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer New England Journal of Medicine 383 (9), 813-824, 2020

5-) Efficacy of Selpercatinib in RET-Altered Thyroid Cancers New England Journal of Medicine 383 (9), 825-835, 2020

ARTICLES

Add your articles